Stock Market Today, Feb: ImmunityBio Up on Anktiva EU OK
ImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
An entry point for newcomers, outlining which blockchains are simplest to learn, set up wallets, and start using.
19,955 articlesImmunityBio sails higher after the EU green lights ANKTIVA for bladder cancer, igniting waves across biotech stocks. ...
A fast-growing company with a software-led model and global expansion is catching investor attention. This growth sto...
Is a recession priced into market? This guide breaks down what pricing in expectations really means, the data to watc...
A seasoned approach to diversification can include a carefully chosen small-cap ETF. This article breaks down how thi...
The Dow tumbled about 800 points as fresh tariff plans and fears over AI disruption spooked investors. Analysts say p...
Bitcoin’s rising hodl cohorts underscore a defensive market, with on-chain metrics showing persistent outflows, minim...
Sitting on a 1.1% S&P yield can feel underwhelming. These three dividend stocks double right now offer stronger incom...
As Veracyte approaches its Q4 2025 earnings, investors want a clear view of revenue momentum, margins, and reimbursem...
Hovnanian Enterprises reports a profit for Q1 2026 as it shifts focus to higher-margin homes. The move aims to lift m...
Navitas Semiconductor shares moved sharply higher as investors weighed strong earnings against exciting long-term gro...
A new round of Iranian strikes tests the region’s missile defenses and buoyed defense stocks, while households weigh ...
Nike has steadied after a challenging period, yet investors should brace for the real test: translating a stabilized ...